GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » athenahealth Inc (NAS:ATHN) » Definitions » Beneish M-Score

athenahealth (athenahealth) Beneish M-Score : 0.00 (As of Apr. 26, 2024)


View and export this data going back to 2007. Start your Free Trial

What is athenahealth Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for athenahealth's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of athenahealth was 0.00. The lowest was 0.00. And the median was 0.00.


athenahealth Beneish M-Score Historical Data

The historical data trend for athenahealth's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

athenahealth Beneish M-Score Chart

athenahealth Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.65 -2.46 -3.06 -3.01 -3.02

athenahealth Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.82 -3.02 -2.97 -3.26 -3.40

Competitive Comparison of athenahealth's Beneish M-Score

For the Health Information Services subindustry, athenahealth's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


athenahealth's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, athenahealth's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where athenahealth's Beneish M-Score falls into.



athenahealth Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of athenahealth for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3568+0.528 * 0.337+0.404 * 0.8684+0.892 * 1.1121+0.115 * 0.9431
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8347+4.679 * -0.134739-0.327 * 0.8095
=-3.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep18) TTM:Last Year (Sep17) TTM:
Total Receivables was $247 Mil.
Revenue was 329.5 + 323.3 + 329.4 + 329.2 = $1,311 Mil.
Gross Profit was 175.1 + 171.3 + 175.4 + 182.9 = $705 Mil.
Total Current Assets was $614 Mil.
Total Assets was $1,589 Mil.
Property, Plant and Equipment(Net PPE) was $337 Mil.
Depreciation, Depletion and Amortization(DDA) was $150 Mil.
Selling, General, & Admin. Expense(SGA) was $352 Mil.
Total Current Liabilities was $224 Mil.
Long-Term Debt & Capital Lease Obligation was $232 Mil.
Net Income was 26.4 + 36.4 + 31.1 + 31.6 = $126 Mil.
Non Operating Income was -1.8 + -2.4 + -2.6 + 3.6 = $-3 Mil.
Cash Flow from Operations was 110.3 + 117.8 + 30.2 + 84.5 = $343 Mil.
Total Receivables was $164 Mil.
Revenue was 304.6 + 301.1 + 285.4 + 288.141 = $1,179 Mil.
Gross Profit was 160.6 + 157.3 + 141 + -245.359 = $214 Mil.
Total Current Assets was $329 Mil.
Total Assets was $1,284 Mil.
Property, Plant and Equipment(Net PPE) was $362 Mil.
Depreciation, Depletion and Amortization(DDA) was $148 Mil.
Selling, General, & Admin. Expense(SGA) was $379 Mil.
Total Current Liabilities was $198 Mil.
Long-Term Debt & Capital Lease Obligation was $258 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(247.3 / 1311.4) / (163.9 / 1179.241)
=0.188577 / 0.138988
=1.3568

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(213.541 / 1179.241) / (704.7 / 1311.4)
=0.181083 / 0.537365
=0.337

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (614.4 + 337) / 1589) / (1 - (329.4 + 361.5) / 1284.3)
=0.401259 / 0.462042
=0.8684

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1311.4 / 1179.241
=1.1121

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(148.011 / (148.011 + 361.5)) / (150 / (150 + 337))
=0.290496 / 0.308008
=0.9431

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(351.5 / 1311.4) / (378.661 / 1179.241)
=0.268034 / 0.321106
=0.8347

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((232.3 + 224) / 1589) / ((258.1 + 197.5) / 1284.3)
=0.287162 / 0.354746
=0.8095

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(125.5 - -3.2 - 342.8) / 1589
=-0.134739

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

athenahealth has a M-score of -3.00 suggests that the company is unlikely to be a manipulator.


athenahealth Beneish M-Score Related Terms

Thank you for viewing the detailed overview of athenahealth's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


athenahealth (athenahealth) Business Description

Traded in Other Exchanges
N/A
Address
Athenahealth provides healthcare IT (HCIT) services through cloud-based and mobile application products largely for smaller to midsize medical groups and health systems. Their services include revenue cycle and practice management, electronic health records, patient engagement, population health management, and care coordination. The business services segment generates 96% of revenue, which provides cloud-based solutions and support to healthcare providers. Athenahealth is headquartered in Waltham, Massachusetts.
Executives
Brian P Mckeon director IDEXX LABORATORIES, ONE IDEXX DRIVE, WESTBROOK ME 04092
John A Kane director C/O MERCHANTS BANCSHARES, INC., 275 KENNEDY DRIVE, SOUTH BURLINGTON VT 05403
Dev Ittycheria director C/O MONGO DB, INC., 1633 BROADWAY, 38TH FLOOR, NEW YORK NY 10019
Ed Park director 311 ARSENAL STREET WATERTOWN MA 02472
Brandon H Hull director 221 NASSAU STREET, PRINCETON NJ 08542
Thomas J Szkutak director P O BOX 81226, SEATTLE WA 98108-1226
Jeffrey R Immelt director, other: Executive Chairman GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Marc A Levine officer: Chief Financial Officer C/O ATHENAHEALTH, INC., 311 ARSENAL STREET, WATERTOWN MA 02472
Jacqueline B Kosecoff director 5960 HEISLEY ROAD, MENTOR OH 44060
Amy Abernethy director 311 ARSENAL STREET, WATERTOWN MA 02472
Kristi Ann Matus officer: EVP and CFAO C/O EQUITABLE HOLDINGS, INC., 1290 AVENUE OF THE AMERICAS, NEW YORK NY 10104
Daniel H. Orenstein officer: SVP, GC, and Secretary 311 ARSENAL STREET, WATERTOWN MA 02472
Jeremy Delinsky officer: SVP, Chief Product Officer C/O WAYFAIR INC., 4 COPLEY PLACE, 7TH FLOOR, BOSTON MA 02116
Timothy M Adams officer: CFO & SVP 311 ARSENAL STREET, WATERTOWN MA 02472
Bryan E Roberts director C/O VENROCK ASSOCIATES, 2494 SAND HILL ROAD STE 200, MENLO PARK CA 94025

athenahealth (athenahealth) Headlines

From GuruFocus

Heliogen, Inc. to Participate in Upcoming Investor Conferences

By Business Wire Business Wire 09-01-2021